Organon (OGN) Return on Equity [ROE] (2020 - 2026)
Organon (OGN) recorded Return on Equity [ROE] of 19.37% in Q3 2026, down 41.76 percentage points from 61.13% a year earlier and down 2.52 percentage points from the prior quarter.
Powered by 
Analysis
Organon (OGN) Return on Equity [ROE] (2020 - 2026) Analysis & Trends
For FY2025, Organon reported Return on Equity [ROE] of 30.56%, down 399.30 percentage points from FY2024.
- Annual Return on Equity [ROE] has a five-year change of -3.95 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at 429.85% in FY2024 and 67.92% in FY2021 (+33.42 pp).
- The Q3 2026 figure is the lowest quarterly Return on Equity [ROE] in data going back to Q4 2020.
- On a year-over-year basis, Return on Equity [ROE] has declined for six consecutive quarters, with an average year-over-year change of -280.60 percentage points over the last six quarters.
- Per Business Quant, the preceding three quarters came in at 21.90% (Q2 2026), 29.73% (Q1 2026) and 22.56% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Organon | 3.65 Bn | -629.18 Mn | 869.00 Mn | 19.37% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 19.37% |
| Jun 30, 2026 | 21.90% |
| Mar 31, 2026 | 29.73% |
| Dec 31, 2025 | 22.56% |
| Sep 30, 2025 | 61.13% |
| Jun 30, 2025 | 109.80% |
| Mar 31, 2025 | 147.93% |
| Dec 31, 2024 | 179.07% |
| Sep 30, 2024 | 408.48% |
| Jun 30, 2024 | 1,041.67% |
| Jun 30, 2021 | 124.89% |
| Mar 31, 2021 | 36.36% |
| Dec 31, 2020 | 33.69% |
API Access
Organon Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "OGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();